Abbott Laboratories (ABT)vsInspire Medical Systems Inc (INSP)
ABT
Abbott Laboratories
$103.10
+1.12%
HEALTHCARE · Cap: $176.41B
INSP
Inspire Medical Systems Inc
$73.00
+7.16%
HEALTHCARE · Cap: $1.92B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 5083% more annual revenue ($46.59B vs $898.74M). INSP leads profitability with a 15.0% profit margin vs 11.7%. INSP trades at a lower P/E of 14.7x. ABT earns a higher WallStSmart Score of 54/100 (C-).
ABT
Buy54
out of 100
Grade: C-
INSP
Buy51
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-37.5%
Fair Value
$74.13
Current Price
$103.09
$28.97 premium
Margin of Safety
+84.2%
Fair Value
$431.37
Current Price
$73.00
$358.37 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Generating 2.1B in free cash flow
Earnings expanding 308.4% YoY
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Earnings declined 47.5%
Smaller company, higher risk/reward
Revenue declined 7.6%
Operating margin of -0.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Free Cash Flow. Revenue growth of 13.0% demonstrates continued momentum.
Bull Case : INSP
The strongest argument for INSP centers on EPS Growth, Debt/Equity, Altman Z-Score.
Bear Case : ABT
The primary concerns for ABT are PEG Ratio, P/E Ratio, EPS Growth.
Bear Case : INSP
The primary concerns for INSP are Market Cap, Revenue Growth, Operating Margin.
Key Dynamics to Monitor
ABT profiles as a value stock while INSP is a declining play — different risk/reward profiles.
INSP carries more volatility with a beta of 0.70 — expect wider price swings.
ABT is growing revenue faster at 13.0% — sustainability is the question.
ABT generates stronger free cash flow (2.1B), providing more financial flexibility.
Bottom Line
ABT scores higher overall (54/100 vs 51/100) and 13.0% revenue growth. INSP offers better value entry with a 84.2% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Inspire Medical Systems Inc
HEALTHCARE · MEDICAL DEVICES · USA
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?